Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 22

Trial Status

Completed5
Other1

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverLung CancerBreast Cancer+1 more
Similarity Score15%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of LiverBreast CancerLung Cancer
Similarity Score11%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerBreast CancerCancer of Liver
Similarity Score11%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LymphomaLymphoproliferative DisordersUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerCancer of LiverLung Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerUnspecified Adult Solid Tumor, Protocol SpecificBreast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorBreast CancerLung Cancer
Similarity Score11%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLymphoproliferative DisordersSolid Tumor

Worked with same sponsors:

Genentech, Inc.National Cancer Institute (NCI)
Similarity Score11%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Lung CancerSolid Tumor
Similarity Score8%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lung CancerBreast Cancer

Worked with same sponsors:

Eli Lilly and CompanyGenentech, Inc.
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00033514Phase 1/2PrincipalInvestigator

Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression

Breast Cancer
Completed
NCT00045318Phase 1StudyChair

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

Unspecified Adult Solid Tumor, Protocol Specific
Completed
NCT00049322Phase 2PrincipalInvestigator

Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery

Liver Cancer
Completed
NCT00052273Phase 1PrincipalInvestigator

LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors

AdultSolid Tumor
Completed
NCT00055926Phase 1PrincipalInvestigator

CP-724,714 in Treating Patients With Metastatic Breast Cancer

Breast Cancer
Completed
NCT00324597Phase 1PrincipalInvestigator

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Lung CancerLymphomaLymphoproliferative Disorder+1 more
Unknown

All 6 trials loaded